Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"High-molecular-weight plasma proteins" is not the canonical name for any single molecule or receptor. Instead, this term refers to a broad class of large proteins found in blood plasma. These include albumin, globulins (alpha, beta, gamma), fibrinogen, complement components, protease inhibitors such as alpha 2-macroglobulin, and others. Each has distinct biological roles: Albumin is the most abundant plasma protein by mass but actually has lower molecular weight compared to many globulins; it maintains oncotic pressure and transports various substances. Globulins are subdivided into alpha 1-, alpha 2-, beta-, and gamma-globulins; they serve in transport functions (e.g., transferrin), immune defense (immunoglobulins/antibodies), enzyme inhibition (e.g., haptoglobin binds free hemoglobin; alpha 2-macroglobulin inhibits proteases), coagulation regulation, and more.[1][3][5] Fibrinogen is essential for blood clotting. Complement components participate in immune responses. Some high-molecular-weight complexes exist between specific plasma proteins—for example between vitamin K-dependent Protein S and C4b-binding protein—but these are individual entities with defined structure/function.[4] Plasma protein concentrations change in many diseases—liver dysfunction reduces synthesis; nephrotic syndrome increases some high-MW species due to altered filtration; inflammation alters acute-phase reactants.[3] Measurement of total or specific fractions serves as important clinical biomarkers but does not constitute targeting a single "receptor" or "enzyme." Because "high-molecular-weight plasma proteins" describes an entire functional class rather than an individual molecule or validated drug target/receptor/enzyme/transporter/etc., it should not be considered a canonical therapeutic target. The entry is too broad for structured annotation at the level required for drug discovery databases. In summary: This term refers collectively to several major classes of circulating blood/plasma macromolecules with diverse physiological roles—including transporters, enzymes/inhibitors, immunoglobulins/antibodies—but does *not* denote any one specific molecular entity suitable for targeted therapy or precise database curation.[1][3][5]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on High-molecular-weight plasma proteins.